Home
AGEN
AGEN News

Latest Agenus Inc. (AGEN) News on April 1, 2025

Business Wire

7 days ago

Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025

Here's Why Agenus (AGEN) Is a Great 'Buy the Bottom' Stock Now

Zacks

7 days ago

Here's Why Agenus (AGEN) Is a Great 'Buy the Bottom' Stock Now

Business Wire

13 days ago

Agenus Unveils Colorectal Cancer Survey Findings, Highlighting the Urgent Need for Treatment Innovation

Agenus Inc (AGEN) Q4 2024 Earnings Call Highlights: Strategic Moves Amid Financial Challenges

GuruFocus.com

21 days ago

Agenus Inc (AGEN) Q4 2024 Earnings Call Highlights: Strategic Moves Amid Financial Challenges

Thomson Reuters StreetEvents

21 days ago

Q4 2024 Agenus Inc Earnings Call

Agenus (AGEN) Q4 2024 Earnings Call Transcript

Motley Fool

21 days ago

Agenus (AGEN) Q4 2024 Earnings Call Transcript

Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates

Zacks

21 days ago

Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates

Associated Press Finance

21 days ago

Agenus: Q4 Earnings Snapshot

Business Wire

21 days ago

Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program

Kura Oncology (KURA) Reports Q4 Loss, Lags Revenue Estimates

Zacks

a month ago

Kura Oncology (KURA) Reports Q4 Loss, Lags Revenue Estimates

Business Wire

a month ago

Agenus Reports Impact of Key Immuno-Oncology Data Presented at Leading Medical Conferences and Peer-Reviewed Publications

Business Wire

a month ago

Agenus to Participate in B. Riley Securities Precision Oncology & Radiopharma Investor Conference

Business Wire

a month ago

Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report

Business Wire

a month ago

Agenus Presents New Botensilimab/Balstilimab Data in Gastric Cancer at AACR IO Annual Meeting

Business Wire

a month ago

CORRECTING and REPLACING Agenus’ BOT/BAL Selected for Two Presentations at Upcoming AACR IO Annual Meeting

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?

Zacks

a month ago

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?

Travere Therapeutics (TVTX) Reports Q4 Loss, Tops Revenue Estimates

Zacks

a month ago

Travere Therapeutics (TVTX) Reports Q4 Loss, Tops Revenue Estimates

Agenus (AGEN) Is Attractively Priced Despite Fast-paced Momentum

Zacks

2 months ago

Agenus (AGEN) Is Attractively Priced Despite Fast-paced Momentum

Are Medical Stocks Lagging Agenus (AGEN) This Year?

Zacks

2 months ago

Are Medical Stocks Lagging Agenus (AGEN) This Year?

Business Wire

2 months ago

Agenus Announces Publication in the Journal of Clinical Oncology Highlighting Data from Botensilimab Plus Balstilimab in Relapsed/Refractory Metastatic Sarcomas

Business Wire

2 months ago

Agenus Presents Data at ASCO GI Demonstrating Impact of BOT/BAL in Colorectal Cancer Across Neoadjuvant and Advanced Disease

What Makes Agenus (AGEN) a New Buy Stock

Zacks

2 months ago

What Makes Agenus (AGEN) a New Buy Stock

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?

Zacks

2 months ago

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?

Business Wire

3 months ago

Agenus Announces Five Presentations at ASCO GI Highlighting BOT/BAL Activity Across Colorectal and Gastric Cancers

AstraZeneca, Daiichi build cancer drug case; Amgen invests $1B

BioPharma Dive

4 months ago

AstraZeneca, Daiichi build cancer drug case; Amgen invests $1B

Business Wire

4 months ago

Agenus Announces Strategic Realignment to Focus on Core Programs and Significantly Reduce Costs

Agenus Gets $22M Mortgage, Plans Strategic Realignment To Focus On Colorectal Cancer Drug Development

Benzinga

4 months ago

Agenus Gets $22M Mortgage, Plans Strategic Realignment To Focus On Colorectal Cancer Drug Development

MT Newswires

4 months ago

Agenus Secures $22 Million Mortgage, Plans Operational Realignment; Shares Jump

Business Wire

4 months ago

Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment

Agenus (AGEN) Loses -41.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

4 months ago

Agenus (AGEN) Loses -41.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Agenus (AGEN) Loses -41.13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

4 months ago

Agenus (AGEN) Loses -41.13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Down -39.39% in 4 Weeks, Here's Why Agenus (AGEN) Looks Ripe for a Turnaround

Zacks

5 months ago

Down -39.39% in 4 Weeks, Here's Why Agenus (AGEN) Looks Ripe for a Turnaround

Thomson Reuters StreetEvents

5 months ago

Q3 2024 Agenus Inc Earnings Call

Agenus Inc (AGEN) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges While ...

GuruFocus.com

5 months ago

Agenus Inc (AGEN) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges While ...

Agenus (AGEN) Q3 2024 Earnings Call Transcript

Motley Fool

5 months ago

Agenus (AGEN) Q3 2024 Earnings Call Transcript

Agenus (AGEN) Reports Q3 Loss, Lags Revenue Estimates

Zacks

5 months ago

Agenus (AGEN) Reports Q3 Loss, Lags Revenue Estimates

Associated Press Finance

5 months ago

Agenus: Q3 Earnings Snapshot

Business Wire

5 months ago

Agenus Reports Third Quarter 2024 Financial Results and Strategic Advancements in BOT/BAL Development

Earnings To Watch: Agenus Inc (AGEN) Reports Q3 2024 Result

GuruFocus.com

5 months ago

Earnings To Watch: Agenus Inc (AGEN) Reports Q3 2024 Result

Business Wire

5 months ago

Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024

Business Wire

5 months ago

Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update

Business Wire

7 months ago

Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas Presented at ESMO 2024

MT Newswires

7 months ago

Agenus Sued by Shareholder for Misleading Investors Over Colorectal Cancer Immuno-Therapy Trial Results

Business Wire

7 months ago

Botensilimab/Balstilimab Clinical Activity in Refractory Sarcomas to be Presented in Oral Session at ESMO 2024

Business Wire

7 months ago

Agenus to Participate in September Investor Conferences

Agenus (AGEN) Q2 2024 Earnings Call Transcript

Motley Fool

8 months ago

Agenus (AGEN) Q2 2024 Earnings Call Transcript

Agenus (AGEN) Reports Q2 Loss, Lags Revenue Estimates

Zacks

8 months ago

Agenus (AGEN) Reports Q2 Loss, Lags Revenue Estimates

Associated Press Finance

8 months ago

Agenus: Q2 Earnings Snapshot

Business Wire

8 months ago

Agenus Announces Appointment of Tom Harrison to Board of Directors

Business Wire

8 months ago

Agenus Reports Second Quarter 2024 Operational and Financial Results

Business Wire

8 months ago

Agenus Publishes Seminal Study on Botensilimab’s Activity in Treatment-Resistant Cancers

Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus

Benzinga

8 months ago

Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus

Bristol Myers sends TIGIT drug back to Agenus

BioPharma Dive

8 months ago

Bristol Myers sends TIGIT drug back to Agenus

Agenus (AGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Zacks

8 months ago

Agenus (AGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical

Zacks

8 months ago

The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical

Business Wire

8 months ago

Agenus to Provide Second Quarter 2024 Financial Report and Corporate Update

Agenus (AGEN) Tanks on Colorectal Cancer Study Interim Data

Zacks

8 months ago

Agenus (AGEN) Tanks on Colorectal Cancer Study Interim Data

Lilly alone in bidding for Morphic; Novartis won’t yet file MorphoSys drug

BioPharma Dive

8 months ago

Lilly alone in bidding for Morphic; Novartis won’t yet file MorphoSys drug

MT Newswires

8 months ago

Agenus Says FDA Advised Against Accelerated Approval for Potential Colorectal Cancer Treatment; Shares Tumble

Business Wire

8 months ago

Agenus Announces End-of-Phase-2 Meeting Outcomes and Topline Interim Phase 2 Data for BOT/BAL in MSS Colorectal Cancer

IGM Biosciences (IGMS) Soars 32.7%: Is Further Upside Left in the Stock?

Zacks

9 months ago

IGM Biosciences (IGMS) Soars 32.7%: Is Further Upside Left in the Stock?

MT Newswires

9 months ago

Sector Update: Health Care Stocks Edge Higher in Afternoon Trading

MT Newswires

9 months ago

Agenus Shares Rise After Trial Shows Tumor Reductions in Colon Cancer Patients

Business Wire

9 months ago

Significant Tumor Reductions in Neoadjuvant MSS Colon Cancer Patients Treated with Botensilimab/Balstilimab Presented at ESMO GI Conference

Business Wire

9 months ago

Cancer Therapy Evaluation Program Announces Availability of Botensilimab for Clinical Studies

Business Wire

9 months ago

Agenus Announces Appointment of Dr. Jennifer Buell to Its Board of Directors

Business Wire

10 months ago

Nature Medicine Reports Agenus’ Novel Immunotherapy Demonstrates Clinical Activity Against a Deadly Form of Colorectal Cancer on the Rise in Americans Under 50

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

CNW Group

10 months ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

10 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

Business Wire

10 months ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts

AFP

10 months ago

New Zealand scraps plan to tax livestock burps, farts

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

The Wall Street Journal

10 months ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

Business Wire

10 months ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

UK Unemployment Rises in Sign Inflationary Pressures Cool

Bloomberg

10 months ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Simply Wall St.

10 months ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Business Wire

10 months ago

Agenus Announces Virtual Annual Shareholders Meeting

Business Wire

10 months ago

Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

10 months ago

Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting

Business Wire

10 months ago

Agenus to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

3 Magnificent Growth Stocks to Buy Hand Over Fist

Motley Fool

10 months ago

3 Magnificent Growth Stocks to Buy Hand Over Fist

Business Wire

a year ago

FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer

Agenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Agenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript

Agenus First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a year ago

Agenus First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

GuruFocus.com

a year ago

Agenus Inc (AGEN) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...

Agenus (AGEN) Q1 2024 Earnings Call Transcript

Motley Fool

a year ago

Agenus (AGEN) Q1 2024 Earnings Call Transcript

MT Newswires

a year ago

Sector Update: Health Care Stocks Stronger in Tuesday Afternoon Trading

MT Newswires

a year ago

Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates

Agenus (AGEN) Reports Q1 Loss, Misses Revenue Estimates

Zacks

a year ago

Agenus (AGEN) Reports Q1 Loss, Misses Revenue Estimates

Agenus Inc (AGEN) Q1 2024 Earnings: Misses Revenue and EPS Estimates Amid Strategic Developments

GuruFocus.com

a year ago

Agenus Inc (AGEN) Q1 2024 Earnings: Misses Revenue and EPS Estimates Amid Strategic Developments

Associated Press Finance

a year ago

Agenus: Q1 Earnings Snapshot

Business Wire

a year ago

Agenus Reports First Quarter 2024 Results

Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement

Business Wire

a year ago

Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement

Business Wire

a year ago

Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement

Up 40%: Is This Red-Hot Growth Stock Still a Buy?

Motley Fool

a year ago

Up 40%: Is This Red-Hot Growth Stock Still a Buy?

Business Wire

a year ago

Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting

Business Wire

a year ago

Agenus to Provide First Quarter 2024 Financial Report and Corporate Update

Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock?

Zacks

a year ago

Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock?

Business Wire

a year ago

Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer

Down 75%. Is Agenus Stock a Buy on the Dip?

Motley Fool

a year ago

Down 75%. Is Agenus Stock a Buy on the Dip?

Business Wire

a year ago

Agenus Announces Reverse Stock Split of Common Stock

Share on Social Networks: